ArticleMedicine2025
ANCA-associated vasculitis after hantavirus infection: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleAntineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a small and medium-vessel vasculitis that often leads to rapidly progressive glomerulonephritis. Although certain infections have been associated with ANCA formation, their role in triggering AAV is not fully understood. PATIENT CONCERNS: A 60-year-old male who tested positive for hantavirus initially presented with fever, cough, and skin rash. Despite treatment with antibiotics for community-acquired pneumonia, his condition worsened, revealing elevated serum creatinine and proteinuria. Subsequent testing identified a significant increase in hantavirus antibody titers and positive anti-myeloperoxidase ANCA antibodies. DIAGNOSIS: Laboratory tests and subsequent renal biopsy confirmed AAV with hantavirus infection.
interventionOral cyclophosphamide and high-dose glucocorticoids were initiated. OUTCOMES: The patient's renal function deteriorated after immunosuppressive treatment, necessitating maintenance hemodialysis. LESSONS: This is the first reported case of AAV following hantavirus infection, underscoring the need for vigilance in distinguishing AAV from other conditions in patients with viral infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.